戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 sing AlgB.D59N or H-AlgB delta1-145 remained mucoid.
2 lony morphology and phenotype referred to as mucoid.
3 s in cystic fibrosis patients are frequently mucoid.
4 ved on solid culture media is referred to as mucoid.
5 monas aeruginosa (PA) as either nonmucoid or mucoid.
6 se-negative lasB::Cm knock-out mutant in the mucoid 8821 background was constructed, and it showed a
7 aeruginosa from cystic fibrosis patients are mucoid (alginate producing) yet lack flagella.
8                   Developing biofilms of the mucoid (alginate-producing) cystic fibrosis pulmonary is
9 s in Pseudomonas aeruginosa, are elevated in mucoid, alginate-producing bacteria and in response to i
10 s at least approximately 1.6-fold greater in mucoid, alginate-producing bacteria than in nonmucoid ba
11 ranscribed in response to iron limitation in mucoid, alginate-producing bacteria.
12                        We demonstrate that a mucoid, alginate-producing strain of Pseudomonas aerugin
13                 The resulting strain was non-mucoid and exhibited no detectable algD transcription.
14                                   A dominant mucoid and hypermutator mutL lineage was replaced after
15    To detect spontaneous mutations in csrRS, mucoid and large colony variants of M1 strain MGAS166 we
16 e &gland, brain, muscle, immune, metabolism, mucoid and nerve conduction.
17 ate that elastase, when overproduced in both mucoid and non-mucoid cells, stimulates alginate synthes
18  serotype A), the switching occurred between mucoid and nonmucoid colonies.
19 imary clinical B. pseudomallei isolates with mucoid and nonmucoid colony morphologies from the same s
20 table for all of the agents tested, for both mucoid and nonmucoid isolates.
21  fibrosis pulmonary isolate FRD1, as well as mucoid and nonmucoid mutant strains, were monitored by A
22 s associated with ARF in the SLC region, 964 mucoid and nonmucoid pharyngeal isolates recovered in SL
23 t in addition to being intracellular in both mucoid and nonmucoid Pseudomonas aeruginosa, Ndk is also
24  found to promote phagocytic killing of both mucoid and nonmucoid strains as well as protection again
25                As expected, a rocA mutant is mucoid and produces more transcript from the has promote
26 be difficult because the organisms are often mucoid and slow growing.
27  study, we observed that in CF isolates, the mucoid and the nonmotile phenotypes occur predominantly
28 robial susceptibilities of 48 CF strains (25 mucoid) and 50 non-CF strains to 12 anti-Pseudomonas age
29 ny size (large, medium, and small) and their mucoid appearance on blood agar.
30 sed HCN production in an alginate-producing (mucoid) background.
31 ious reports of increased algR expression in mucoid backgrounds, and RpoS additionally plays a role i
32 also are cotranscribed in both nonmucoid and mucoid backgrounds.
33                More importantly, HNO2 killed mucoid bacteria (a) in anaerobic biofilms; (b) in vitro
34                      These data suggest that mucoid bacteria either are in an iron-starved state rela
35                            Here we show that mucoid bacteria perish during anaerobic exposure to 15 m
36                                              Mucoid bacteria produced approximately twofold-higher le
37                     Increased proportions of mucoid bacteria were isolated during exacerbations occur
38 bits and elicited opsonic antibodies against mucoid but not nonmucoid P. aeruginosa, but nonetheless
39 X-treated mice also had dramatically reduced mucoid cell hyperplasia, and airway responsiveness retur
40  peribronchial eosinophilic infiltration and mucoid cell hyperplasia.
41 -kDa Ndk-Scs complex specifically present in mucoid cell predominantly synthesizes GTP and UTP but no
42 omplex media but is greatly reduced when the mucoid cells are grown in mineral salts media or in pres
43 osa is greatly reduced in alginate-secreting mucoid cells isolated from the lungs of cystic fibrosis
44                                           In mucoid cells of P. aeruginosa, Ndk is also known to exis
45 22) P. aeruginosa strains were compared, the mucoid cells were cleared several-fold less efficiently
46 se, when overproduced in both mucoid and non-mucoid cells, stimulates alginate synthesis.
47                   We sequenced algK from the mucoid CF isolate FRD1 and expressed it in Escherichia c
48 otype of an DeltaalgL mutation in the highly mucoid CF isolate FRD1.
49  algZ deletion mutant was constructed in the mucoid CF isolate FRD1.
50  the secretion is triggered primarily in the mucoid CF isolate of strain 8821M (or in strain FRD1) bu
51                                    A typical mucoid CF isolate, FRD1, and its isogenic mutants were t
52 The overall frequency of mucA alterations in mucoid CF isolates was 84%.
53               The mucA22 allele is common in mucoid CF isolates.
54  90% reduction in alginate production in the mucoid, CF isolate, P. aeruginosa FRD1.
55 ariner transposon library using CF149, a non-mucoid clinical isolate with a misssense mutation in alg
56 r, the average amount of cyanide produced by mucoid clinical isolates was 4.7 +/- 0.85 micromol of HC
57 increase in bacterial hyaluronan production (mucoid colonies 200 mug per CFU and no detectable capsul
58 tified as csrR, caused the strain to produce mucoid colonies and to increase transcription of hasA, t
59 ive ("flesh-eating") infection often grow as mucoid colonies on primary culture but lose this colony
60  no detectable capsule production in the non-mucoid colonies).
61 between small, dry, compact and larger, more mucoid colonies.
62 ooth colony (SM) switches to a more virulent mucoid colony (MC) variant.
63 23.7%) isolates lacked the typical button or mucoid colony appearance of S. pneumoniae.
64 syrA was identified by its ability to confer mucoid colony morphology and by its ability to suppress
65 solates from these patients typically have a mucoid colony morphology due to overproduction of the ex
66 3 produced a transconjugant that exhibited a mucoid colony morphology, reflecting increased hyaluroni
67  the exopolysaccharide alginate resulting in mucoid colony morphology.
68 The hldD, hldE, and waaF mutants exhibited a mucoid colony phenotype due to production of a colanic a
69                             Organisms with a mucoid colony phenotype when grown on blood agar plates
70 lymer poly-gamma-glutamate (PGA) to confer a mucoid colony phenotype.
71 a usually undergoes a phenotypic switch to a mucoid colony, which is characterized by the overproduct
72 h cells from smooth-colony variants (SM) and mucoid-colony variants (MC) arising from phenotypic swit
73                   These results suggest that mucoid conversion and inhibition of invasive virulence d
74                                 However, the mucoid conversion can occur in wt mucA strains via the d
75            These observations suggested that mucoid conversion in CF may be driven by a selection for
76  that reducing activity of RpoD is linked to mucoid conversion in CF149.
77 omoter caused the overexpression of MucE and mucoid conversion in P. aeruginosa strains PAO1 and PA14
78 ion of the exopolysaccharide alginate causes mucoid conversion in Pseudomonas aeruginosa and is a poo
79 coid isolation, increased exacerbations, and mucoid conversion in vivo.
80                                              Mucoid conversion is indicative of overproduction of a c
81           In this study we hypothesized that mucoid conversion may be part of a larger response that
82                Estradiol and estriol induced mucoid conversion of P. aeruginosa in women with cystic
83 th cystic fibrosis are at increased risk for mucoid conversion of Pseudomonas aeruginosa, which contr
84 e C terminus of MucE (WVF) were required for mucoid conversion via two predicted proteases AlgW (DegS
85   Thus, even though dsbA is coregulated with mucoid conversion, it was not required for alginate prod
86 n cystic fibrosis patients typically undergo mucoid conversion.
87 order to identify protein levels enhanced by mucoid conversion.
88 factor MucA is a well-accepted mechanism for mucoid conversion.
89 ationic polypeptide-depleted fluid against a mucoid cystic fibrosis isolate of P. aeruginosa.
90  we tested wild-type strains PAO1, PA14, the mucoid cystic fibrosis isolate, FRD1 (mucA22+), and the
91  show here that a null mutation in kinB in a mucoid cystic fibrosis isolate, P. aeruginosa FRD1, did
92 structure of microvessel walls, formation of mucoid cysts initiated in the proximity of damaged micro
93                              The severity of mucoid degeneration and chondroid metaplasia in the ACL
94 ar appearance, pronounced vacuolization, and mucoid degeneration, appearing as Wallerian degeneration
95 e found that P. aeruginosa strain PAO1 and a mucoid derivative of strain PAO1 each grew at dissolved
96  large fraction of P. aeruginosa CF isolates mucoid, did not abrogate AlgU-MucA interactions, althoug
97 iants of Cryptococcus neoformans (smooth and mucoid) differed in their abilities to promote increased
98 ns associated with cystic fibrosis are often mucoid due to the copious production of alginate, an exo
99                         lon mutants are also mucoid, due to the stabilization of another Lon substrat
100                             In addition, two mucoid E. faecalis isolates from patients with chronic u
101 r (TNF)-alpha, a proinflammatory cytokine in mucoid effusion, markedly increased Muc2 mucin mRNA expr
102                                          The mucoid exopolysaccharide (MEP) from P. aeruginosa has be
103 he opsonic antibody activity specific to the mucoid exopolysaccharide (MEP) surface antigen.
104 than those involved in the production of the mucoid exopolysaccharide alginate, are turned on during
105 aboration of the extracellular, O-acetylated mucoid exopolysaccharide, or alginate, is a major microb
106  upon the conversion of P. aeruginosa to the mucoid, exopolysaccharide alginate-overproducing phenoty
107                            The conversion to mucoid, exopolysaccharide alginate-overproducing phenoty
108  from cystic fibrosis (CF) patients is their mucoid, exopolysaccharide alginate-overproducing phenoty
109      Similar experiments were performed with mucoid films collected from the inferior conjunctival fo
110 ular surface in DED patients and abundant in mucoid films.
111 use conversion from a typical nonmucoid to a mucoid form in the CF lung.
112 ix to eight times as intense as those of the mucoid FRD1 parent strain.
113 he algT-mucABCD operon, MucD was detected in mucoid (FRD1) and nonmucoid (PAO1) parental strains and
114                                         Four mucoid fur mutants produced 1.7- to 2.6-fold-greater fum
115 ignal intensities and the so-called inverted mucoid impaction signal (IMIS) sign was qualitatively an
116                                 This type of mucoid induction requires the alternate sigma factor Rpo
117  wild-type mice challenged with an LPS-rough mucoid isolate of P. aeruginosa lacking the CFTR ligand.
118                           In some instances, mucoid isolates of P. aeruginosa were recovered from lun
119                                              Mucoid isolates were more likely to be hypermutators.
120 ratory strains and early lung colonizing non-mucoid isolates with a wt mucA.
121                                 However, for mucoid isolates, correlation coefficients (r values) for
122  they were significantly less effective with mucoid isolates.
123  show greater expression of the gene than do mucoid isolates.
124 tro and were associated with selectivity for mucoid isolation, increased exacerbations, and mucoid co
125 y and proteomic analyses were performed on a mucoid kinB mutant and an isogenic nonmucoid kinB rpoN d
126 ction from laboratory isolates revealed that mucoid laboratory strains made sevenfold more HCN than t
127 gulated using isogenic S. aureus MN8 and MN8 mucoid (MN8m) strains, the latter of which constitutivel
128 atients with cystic fibrosis often display a mucoid morphology due to high levels of expression of th
129 re to estradiol, P. aeruginosa adopted early mucoid morphology, whereas short-term exposure inhibited
130 romoter of rpoH was found to be activated in mucoid mucA mutants.
131                       Alginate production in mucoid (MucA-defective) Pseudomonas aeruginosa is depend
132                                              Mucoid, mucA mutant Pseudomonas aeruginosa cause chronic
133          When isogenic nonmucoid (mucA+) and mucoid (mucA22) P. aeruginosa strains were compared, the
134           However, inactivation of algZ in a mucoid mutant P. aeruginosa strain, which had AlgU freed
135                 Compared with MGAS166, these mucoid mutants are more hemolytic and cause significantl
136                                        Three mucoid mutants were identified with transposon insertion
137 ts showed that ectopic expression of FleQ in mucoid, nonmotile CF isolates restored flagellum biosynt
138 that AlgT inhibits flagellum biosynthesis in mucoid, nonmotile P. aeruginosa cystic fibrosis isolates
139  a repressor of fleQ, we mutated amrZ in the mucoid, nonmotile P. aeruginosa strain FRD1.
140 ntation of the mutant with amrZ restored the mucoid, nonmotile phenotype.
141 he cystic fibrosis lung frequently display a mucoid, nonmotile phenotype.
142 ibits lawn bordering and roaming behavior on mucoid nonpathogenic bacteria and loss of pathogen avoid
143 charge was frequent or very frequent in 85%, mucoid or mucopurulent in 90%, and moderate to severe in
144 hose in desert tortoises and include serous, mucoid, or purulent discharge from the nares, excessive
145                                              Mucoid otitis media (MOM) is characterized by viscous fl
146          CF cells sequentially infected with mucoid P. aeruginosa (MPA) and RV showed lower levels of
147 tor was also associated with reduced odds of mucoid P. aeruginosa (OR, 0.77; P = .013) and Aspergillu
148 ction chromatography of the crude extract of mucoid P. aeruginosa 8821, a CF isolate.
149 nse of cystic fibrosis and wild-type mice to mucoid P. aeruginosa administered by insufflation.
150 ntion of active elastase in the periplasm of mucoid P. aeruginosa and its role in the generation of t
151 sponse regulators activate alginate genes in mucoid P. aeruginosa appears not to be mediated by conve
152 l therapeutics directed against biofilms and mucoid P. aeruginosa are being developed.
153  it may play an important role in protecting mucoid P. aeruginosa biofilm bacteria from the human imm
154 ture and extracellular matrix composition of mucoid P. aeruginosa biofilms, through increased express
155                                         Thus mucoid P. aeruginosa cells elaborate enzymes that modula
156 creted into the extracellular environment by mucoid P. aeruginosa cells.
157  identified a protein(s), AlgZ, expressed in mucoid P. aeruginosa CF isolates that specifically bound
158  The calcium-induced extracellular matrix of mucoid P. aeruginosa consists primarily of the virulence
159 o the important clinical goal of eradicating mucoid P. aeruginosa from the CF airways.
160  investigated mechanisms of the emergence of mucoid P. aeruginosa in CF by analyzing the status of mu
161                             The emergence of mucoid P. aeruginosa in CF is associated with increased
162                             The emergence of mucoid P. aeruginosa in CF is associated with respirator
163 ing to the morbidity and mortality caused by mucoid P. aeruginosa in CF.
164 ung infections could not be established with mucoid P. aeruginosa in either cystic fibrosis or wild-t
165 fection, chronic P. aeruginosa infection and mucoid P. aeruginosa in individuals with cystic fibrosis
166 on of antibodies mediated opsonic killing of mucoid P. aeruginosa in vitro.
167     Indeed, chronic infection of the lung by mucoid P. aeruginosa is a major cause of morbidity and m
168              A mutation in the algR2 gene of mucoid P. aeruginosa is known to exhibit a nonmucoid (no
169 hesis by laboratory and clinical isolates of mucoid P. aeruginosa is necessary and sufficient to atte
170 airway epithelia to the stimuli presented by mucoid P. aeruginosa is not proinflammatory and, hence,
171 lyzing the status of mucA in a collection of mucoid P. aeruginosa isolates from 53 CF patients.
172           Comparison of paired nonmucoid and mucoid P. aeruginosa isolates from three CF patients ind
173                               Interestingly, mucoid P. aeruginosa isolates from urinary tract infecti
174 enance of biofilms produced by nonmucoid and mucoid P. aeruginosa isolates.
175 rogated AIgU-dependent rpoH transcription in mucoid P. aeruginosa laboratory isolates and CF isolates
176 pared with wild-type controls in the face of mucoid P. aeruginosa lung infection.
177 in CF is the result of a global induction in mucoid P. aeruginosa of lipoproteins that act as proinfl
178                   Our data indicate that (i) mucoid P. aeruginosa regardless of their origin (laborat
179 Transcriptional profiling analyses comparing mucoid P. aeruginosa strains to their isogenic algR dele
180 tibility testing of CF strains, particularly mucoid P. aeruginosa strains, is unknown.
181 ere similar in mice exposed to nonmucoid and mucoid P. aeruginosa throughout the infection.
182 tion of alginate maximizes the resistance of mucoid P. aeruginosa to antibody-independent opsonic kil
183 te plays an important role in the ability of mucoid P. aeruginosa to form biofilms and to resist comp
184 is the molecular basis for the resistance of mucoid P. aeruginosa to normally nonopsonic but alginate
185 ds or beads containing a clinical isolate of mucoid P. aeruginosa were instilled in the right lung of
186          We have previously reported that in mucoid P. aeruginosa, an intracellular protease cleaves
187          The recognition of genes induced in mucoid P. aeruginosa, other than those associated with a
188 ng that AlgR activates hcnA transcription in mucoid P. aeruginosa.
189 lobal responses to infection with motile and mucoid P. aeruginosa.
190  when the bulk of alginate is synthesized by mucoid P. aeruginosa.
191                  Elastase is secreted in non-mucoid P. aeruginosa.
192  patients, encounters alginate elaborated by mucoid P. aeruginosa.
193 isk factors, only respiratory infection with mucoid PA correlated significantly with bronchiectasis (
194  isolates were more likely to be infected by mucoid PA, and they showed a narrow T-cell epitope respo
195 cantly related to respiratory infection with mucoid PA; attempts to prevent bronchiectasis should inc
196                    Disruption of dsbA in the mucoid PDO300 background did not affect alginate product
197 Overexpression of algW in PAO1 resulted in a mucoid phenotype and alginate production, even in the ab
198 tion of phpA was found to correlate with the mucoid phenotype and an increase in algD transcription i
199  system that, when inactivated, results in a mucoid phenotype and enhanced virulence in mouse infecti
200 biofilms and the selection of mutants with a mucoid phenotype are major adaptations that allow its pe
201  conversion of Pseudomonas aeruginosa to the mucoid phenotype coincides with the establishment of chr
202 ion of invasive virulence factors and have a mucoid phenotype due to the production of an alginate ca
203                            The conversion to mucoid phenotype in Pseudomonas aeruginosa during chroni
204                                          The mucoid phenotype indicates alginate overproduction and i
205                                          The mucoid phenotype is due to abundant production of the hy
206 well-studied mechanism for transition to the mucoid phenotype is mutation of mucA, leading to loss of
207 regulator of both sigma(22) activity and the mucoid phenotype is the cognate anti-sigma factor MucA.
208  we demonstrated that in vivo switching to a mucoid phenotype occurred in two mice strains and was as
209 ere identified as positive regulators of the mucoid phenotype on PIAAMV.
210  Conversion of Pseudomonas aeruginosa to the mucoid phenotype plays a major role in the pathogenesis
211                                          The mucoid phenotype results from loss-of-function mutations
212          The alginate-overproducing (Alg(+)) mucoid phenotype seen in the CF isolates is extremely un
213 rity, and in the concomitant appearance of a mucoid phenotype that is reminiscent of cells in the ear
214 y have negative effects on expression of the mucoid phenotype under the conditions tested.
215                             Reversion to the mucoid phenotype was associated with reversion of the mu
216 The algXDelta::Gm mutant was restored to the mucoid phenotype with wild-type P. aeruginosa algX provi
217 opolysaccharide abundance (contributing to a mucoid phenotype).
218 riant was experimentally proven to cause the mucoid phenotype, and corresponding resistance to phagoc
219 tic susceptibility, capsule composition, and mucoid phenotype.
220 s, P. aeruginosa undergoes a conversion to a mucoid phenotype.
221 saccharide, alginate, giving these strains a mucoid phenotype.
222 ause alginate overproduction, resulting in a mucoid phenotype.
223 lginate, an exopolysaccharide that confers a mucoid phenotype.
224 ss of O-antigen synthesis alternating with a mucoid phenotype.
225 kground was constructed, and it showed a non-mucoid phenotype.
226 classic feature of CF airway isolates is the mucoid phenotype.
227  the host immune system, and conversion to a mucoid phenotype.
228  P. aeruginosa strains PAO1 and PA14 are non-mucoid, producing minimal amounts of alginate.
229 enBank database with only weak similarity to mucoid protein sequences.
230                               In conclusion, mucoid Pseudomonas adapted to the CF-lung remained able
231 [FEV(1)]) of the CFTR gene genotype, gender, mucoid Pseudomonas aeruginosa (MPA) infection status, pr
232                                              Mucoid Pseudomonas aeruginosa (n = 12; 15%) and nontuber
233 iated with chronic pulmonary infections with mucoid Pseudomonas aeruginosa (PA).
234 tics, tobramycin and ciprofloxacin, into non-mucoid Pseudomonas aeruginosa biofilms.
235 fficacy of azithromycin in a murine model of mucoid Pseudomonas aeruginosa endobronchial infection.
236  maintenance of chronic lung infections with mucoid Pseudomonas aeruginosa in patients with cystic fi
237  The exopolysaccharide alginate, produced by mucoid Pseudomonas aeruginosa in the lungs of cystic fib
238 tible to chronic pulmonary disease caused by mucoid Pseudomonas aeruginosa strains that overproduce t
239                                       In non-mucoid Pseudomonas aeruginosa strains, the Pel and Psl p
240 ciated with chronic pulmonary infection with mucoid Pseudomonas aeruginosa.
241 c bacteria and loss of pathogen avoidance on mucoid Pseudomonas aeruginosa.
242 tors in nontypeable, alginate overproducing (mucoid) Pseudomonas aeruginosa strains isolated from cys
243  we screened a transposon library in the non-mucoid reference strain PAO1, and identified a mutant th
244  were found to display phenotypes which were mucoid relative to the phenotype of the parental algB st
245 s been attributed to accumulation of viscous mucoid secretions in intrahepatic bile ducts.
246 hrough viscoelastic cervical mucus and other mucoid secretions to reach the site of fertilization.
247      By using a representative strain of the mucoid serotype 3 clone, rough phase variants with a div
248 ations were found to be strain specific: the mucoid strain 18A experienced mutations in alginate prod
249 ies from isogenic nonmucoid strain 4095a and mucoid strain 4095c were further investigated.
250  whether these proteins were enhanced in the mucoid strain due to increased transcription.
251 genesis of nonmucoid algB derivatives of the mucoid strain FRD1 was employed.
252 gG activity, a mutant was constructed in the mucoid strain FRD1 with a defined non-polar deletion of
253                 Herein we show that a highly mucoid strain of E. coli K-12 ligates CA repeats to a si
254 on the eradication of biofilms formed by the mucoid strain of Pseudomonas aeruginosa and investigated
255 FU of group B streptococci or 10(7) CFU of a mucoid strain of Pseudomonas aeruginosa by intratracheal
256                                          For mucoid strain P. aeruginosa FRD1, calcium addition (1.0
257 eatment with S-nitrosoglutathione, while the mucoid strain PAO578II showed no further upregulation ab
258 pted agar bead murine model using a clinical mucoid strain that demonstrates the key features of tran
259 teins that were clearly more abundant in the mucoid strain were observed.
260                                 However, the mucoid strains can revert to nonmucoidy in vitro through
261                                          Non-mucoid strains can use either Pel or Psl as the primary
262 tions are cleared but chronic infection with mucoid strains ensues in the majority of CF patients and
263                           Here, we show that mucoid strains of bacteria that produce an exopolysaccha
264                           In the presence of mucoid strains of bacteria, the C. elegans laboratory wi
265                    However, certain clinical mucoid strains of P. aeruginosa have a wild-type (wt) mu
266 odies broadly cross-reactive to heterologous mucoid strains of P. aeruginosa.
267  an extracellular polysaccharide produced by mucoid strains of Pseudomonas aeruginosa that are typica
268                          The second were the mucoid strains Smith diffuse and M, both of which encode
269 on resulted in suppression of mucoidy in all mucoid strains tested, indicating that sigma factor comp
270 ent promoter (PssrA ) was more active in non-mucoid strains than in isogenic mucoid variants.
271 l), is required for biofilm formation in non-mucoid strains that do not rely on alginate as the princ
272 uggests that the reduced CBC observed in the mucoid strains was due to masking of the collagen adhesi
273 ) of nonmucoid strains and 40% (24 of 60) of mucoid strains were definitively identified as Pseudomon
274 n were non-CF strains (P < 0.0001), although mucoid strains were not more likely to have serious disc
275                                              Mucoid strains with mucA mutations predominantly populat
276 enhanced or reduced formation of alginate in mucoid strains, respectively.
277 ved from Pseudomonas lipoproteins induced in mucoid strains.
278 d the presence of mucA mutations only in the mucoid strains.
279 tL lineage was replaced after 11 days by non-mucoid strains.
280    MAb-reactive (nonmucoid) and nonreactive (mucoid) strains from the same patient exhibited identica
281 onic acid capsule on highly encapsulated, or mucoid, strains.
282           Selection of both pre-existing non-mucoid subpopulations and of novel phenotypic traits sug
283                      Similar to cells of the mucoid switch variant, all1Delta cells produced a larger
284 und to be downregulated in the hypervirulent mucoid switch variant, both during logarithmic growth an
285  mimicked the hypervirulent phenotype of the mucoid switch variant, which is characterized by decreas
286 hese mutants ranged from being only slightly mucoid to being indistinguishable from that of the origi
287                      One of the particularly mucoid transposon mutants was chosen for further study.
288 erotype 19 gives rise to variants (the small mucoid variant [SMV] and the acapsular small-colony vari
289                       Rats infected with the mucoid variant developed increased ICP, whereas rats inf
290                                    The large mucoid variant formed flat unstructured biofilms, failed
291 brain fungal burdens were comparable between mucoid variant- and smooth parent-infected rats.
292  cerebrospinal fluid (CSF) fungal burden for mucoid variant-infected rats, although brain fungal burd
293 intensity over the surfaces of the brains of mucoid variant-infected rats.
294 charide accumulated in the CSF and brains of mucoid variant-infected rats.
295 tic inflammatory response in the meninges of mucoid variant-infected rats.
296                                              Mucoid variants appeared at later biofilm developmental
297                                              Mucoid variants of the opportunistic pathogen Pseudomona
298                 Low oxygen tension growth of mucoid variants readily selects for nonmucoid variants.
299 ctive in non-mucoid strains than in isogenic mucoid variants.
300                             In contrast, the mucoid wild-type strain produced only polymerized uronic

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top